Anne-Christine Carlsson, Legal Representative

Title: Anne-Christine Carlsson: Innovator in Apoptosis Induction

Introduction

Anne-Christine Carlsson is a prominent inventor and legal representative based in Lund, Sweden. She has made significant contributions to the field of biotechnology, particularly in the development of binding molecules that target specific cell surface antigens. Her work has implications for therapeutic applications, especially in inducing apoptosis in target cells.

Latest Patents

Anne-Christine holds a patent for ICAM-1 binding antibodies. This invention provides binding molecules, including antibody molecules that selectively bind to a cell surface antigen of a target cell. Upon binding to the cell surface antigen, these molecules induce apoptosis of the target cell. The patent also includes methods and pharmaceutical compositions for apoptosis induction and their uses. She has 1 patent to her name.

Career Highlights

Anne-Christine is associated with Bioinvent International AB, a company known for its innovative approaches in the biotechnology sector. Her role as a legal representative allows her to navigate the complexities of patent law while contributing to groundbreaking research and development.

Collaborations

Throughout her career, Anne-Christine has collaborated with notable colleagues, including Björn Frendéus and Roland Carlsson. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Anne-Christine Carlsson is a key figure in the field of biotechnology, with her work on ICAM-1 binding antibodies paving the way for advancements in apoptosis induction. Her contributions continue to impact the industry positively.